ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
18.611,31
-0,39%
S&P 500
5.306,04
0,02%
Dow Jones
38.852,86
-0,55%
Euro vs US Dollar
1,08363
-0,16%
Bitcoin
67.800,49
-0,72%
Registration Strip Icon for alerts Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ
  6. Forte Biosciences Inc (FBRX)

  7. Forte Biosciences Inc (FBRX) News

FBRX

Forte Biosciences (FBRX)

Forte Biosciences Inc
Von:
Sortieren nach:
 Showing the most relevant articles for your search:NASDAQ:FBRX
DatumZeitQuelleÜberschriftSymbolFirma
13/05/202422h15Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:FBRXForte Biosciences Inc
13/05/202422h06Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:FBRXForte Biosciences Inc
16/02/202422h16Edgar (US Regulatory)Form 8-K/A - Current report: [Amend]NASDAQ:FBRXForte Biosciences Inc
14/02/202422h54Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:FBRXForte Biosciences Inc
05/01/202423h27Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]NASDAQ:FBRXForte Biosciences Inc
03/01/202422h04Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:FBRXForte Biosciences Inc
03/01/202422h01Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:FBRXForte Biosciences Inc
20/12/202316h56Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:FBRXForte Biosciences Inc
16/12/202300h29Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:FBRXForte Biosciences Inc
13/12/202301h30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:FBRXForte Biosciences Inc
09/12/202301h20Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:FBRXForte Biosciences Inc
08/12/202322h05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:FBRXForte Biosciences Inc
22/11/202323h51Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:FBRXForte Biosciences Inc
13/11/202322h05Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:FBRXForte Biosciences Inc
03/10/202322h29Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:FBRXForte Biosciences Inc
03/10/202322h26Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:FBRXForte Biosciences Inc
26/09/202322h16Edgar (US Regulatory)Form 8-K/A - Current report: [Amend]NASDAQ:FBRXForte Biosciences Inc
20/09/202323h55Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:FBRXForte Biosciences Inc
20/09/202323h54Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:FBRXForte Biosciences Inc
20/09/202323h53Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:FBRXForte Biosciences Inc
20/09/202323h49Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:FBRXForte Biosciences Inc
20/09/202323h48Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:FBRXForte Biosciences Inc
20/09/202322h15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:FBRXForte Biosciences Inc
20/09/202322h05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:FBRXForte Biosciences Inc
14/09/202322h00Edgar (US Regulatory)Form DFAN14A - Additional definitive proxy soliciting materials filed by non-management and Rule 14(a)(12) materialNASDAQ:FBRXForte Biosciences Inc
14/09/202316h50Business WireISS and Glass Lewis Recommend Forte Biosciences Stockholders Vote FOR Boardroom Change at the Company’s Upcoming Annual MeetingNASDAQ:FBRXForte Biosciences Inc
11/09/202306h15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:FBRXForte Biosciences Inc
08/09/202322h36Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:FBRXForte Biosciences Inc
06/09/202322h31Edgar (US Regulatory)Form DFAN14A - Additional definitive proxy soliciting materials filed by non-management and Rule 14(a)(12) materialNASDAQ:FBRXForte Biosciences Inc
06/09/202321h15Business WireConcerned Stockholders of Forte Biosciences and Its Independent Director Candidates Share Key Facts that Reinforce the Need for Urgent Change in the Company’s BoardroomNASDAQ:FBRXForte Biosciences Inc
 Showing the most relevant articles for your search:NASDAQ:FBRX

Kürzlich von Ihnen besucht

EU
U162S
U162S
NYSE
JZJ.CL
DGFX
BINGOUSDT
TomorrowLand
BIT
P20JT2
NLBNPIT20JT2 20240920 11
BIT
P1DGN5
BNP Paribas Issuance
ASX
HZRO
Hazer
LSE
45JL
Hsbc Bk.30
LBNK
KUNCIUSDT
Kunci Coin
FTSE
E3X40
FTSEurofirst 300 Consume...
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten